Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: The effect of no treatment and high-dose amiodarone. A randomized, placebo-controlled study

European Heart Journal

Volumn 20, Issue 24, 1999, Pages 1833-1842

  Cotter, G ^a   Blatt, A ^a   Kaluski, E ^a   Metzkor Cotter, E ^a   Koren, M ^a   Litinski, I ^a   Simantov, R ^a   Moshkovitz, Y ^a   Zaidenstein, R ^a   Peleg, E ^a   Vered, Z ^a   Golik, A ^a  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

Amiodarone; Conversion to normal sinus rhythm; Paroxysmal atrial fibrillation

Indexed keywords

AMIODARONE; CLOXACILLIN; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HUMAN; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; PHLEBITIS; PRIORITY JOURNAL; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SINUS RHYTHM;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SAFETY; TACHYCARDIA, PAROXYSMAL;

EID: 0032761587     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1999.1747     Document Type: Article

References (21)

1. Myerburg RJ, Kessler KM, Castellanos A. Recognition, clinical assessment and management of arrhythmias and conduction disturbances. In: The Heart, 8th ed. Hurst 725-8.
2. Pritchett E. Management of atrial fibrillation. N Engl J Med 1992; 326: 1264-9.
3. Galve E, Rivs T, Ballester R et al. Intravenous amiodarone in treatment of recent onset atrial fibrillation: results of a randomized, controlled study. J Am Coll Cardiol 1996; 27: 1079-82.
4. Nattel S. Newer developments in the management of atrial fibrillation. Am Heart J 1995; 130: 1094-106.
5. Botto GL, Capucci A, Boriani G et al. Conversion of recent onset atrial fibrillation to sinus rhythm using a single oral loading dose of propafenon: comparison of two regiments. Int Cardiol 1997; 58: 55-61.
6. Azpitarte J, Alvarez M, Baun O et al. Value of single oral loading dose of propafenon in converting recent-onset atrial fibrillation. Results of a randomized, double blind, controlled study. Eur Heart J 1997; 18: 1649-54.
7. Buscarini L, Imberti D. Increased incidence of spontaneous conversion to sinus rhythm in patients with paroxysmal atrial fibrillation. G Ital Cardiol 1992; 22: 949-52.
8. Botto GL, Bonini T, Broffonui S et al. Conversion of recent onset atrial fibrillation with single oral dose of propafenon: is in hospital admission absolutely necessary? PACE 1996; 19: 1939-43.
9. Fresco C, Proclemer A, Pavan A et al. Intravenous propafenon in paroxysmal atrial fibrillation: a randomized placebo controlled, double blind, multicenter clinical trial. Paroxysmal atrial fibrillation Italian trial (PAFIT) -2 investigators. Clin Cardiol 1996; 19: 409-12.
10. Boriani G, Capucci A, Lenzi T, Sanguinetti M, Magnani B. Propafenon for conversion of recent-onset atrial fibrillation. Chest 1995; 108: 355-8.
11. Bellandi F, Dabizzi RB, Cantini F, DiNatale M, Nicoli L. Intravenous propafenon: efficacy and safety in the conversion to sinus rhythm of recent onset atrial fibrillation- a single blind placebo controlled study. Card Drug Ther 1996; 10: 153-7.
12. Ellenbogen KA, Clemo HF, Stambler BS, Wood MA, VerderLugt JT. Efficacy of ibutalide for termination of atrial fibrillation and flutter. Am J Cardiol 1996; 78 (Suppl 8A): 42-5.
13. Stambler BS, Wood MA, Ellenbogen KA et al. Efficacy and safety of repeated intravenous doses of ibutalide for rapid conversion of atrial flutter or fibrillation. Circulation 1996; 94: 1613-21.
14. Maisel WH, Kuntz KM, Reimond SL et al. Risk of initiating antiarrhythmic drug therapy for atrial fibrillation in patients admitted to a university hospital. Ann Intern Med 1997; 127: 281-4.
15. Podrid PJ. Amiodarone: reevaluation of an old drug. Ann Intern Med 1995; 122: 689-700.
16. Vietti-Ramus G, Veglio F, Marchisio U, Burzio P, Latini R. Efficacy and safety of short intravenous amiodarone in supraventricular tachyarrhythmias. Int J Cardiol 1992; 35: 77-85.
17. Hou ZY, Chang MS, Chen CY et al. Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regiment of intravenous amiodarone. A randomized, digoxin-controlled study. Eur Heart J 1995; 16: 521-8.
18. Boriani G, Biffi M, Capucci A et al. Oral propafenon to convert resent onset atrial fibrillation in patients with and without underlying heart disease: a randomized, controlled trial. Ann Intern Med 1997; 126: 621-5.
19. Horowitz LN, Spielman SR, Greenspan AM et al. Use of amiodarone in the treatment of persistent and paroxysmal atrial fibrillation resistant to quinidine therapy. J Am Coll Cardiol 1985; 6: 1402-7
20. Hoglund C, Rosenhamer G. Echocardiographic left atrial dimension as a predictor of maintaining sinus rhythm after conversion of atrial fibrillation. Acta Med Scand 1985; 217: 411-5.
21. Flaker GC, Fletcher KA, Rothbart RM, Halperin JL, Hart RG. Clinical and echocardiographic features of intermittent atrial fibrillation that predict recurrent atrial fibrillation. Stroke prevention in atrial fibrillation (SPAF) investigators. Am J Cardiol 1995; 76: 355-8.